nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—SLC22A2—Progesterone—uterine cancer	0.208	1	CbGbCtD
Dinoprost Tromethamine—PTGFR—corpus luteum—uterine cancer	0.0531	0.153	CbGeAlD
Dinoprost Tromethamine—TBXA2R—artery—uterine cancer	0.0196	0.0565	CbGeAlD
Dinoprost Tromethamine—PTGIR—artery—uterine cancer	0.0106	0.0306	CbGeAlD
Dinoprost Tromethamine—GALR3—uterus—uterine cancer	0.0104	0.0299	CbGeAlD
Dinoprost Tromethamine—GALR3—female reproductive system—uterine cancer	0.00934	0.0269	CbGeAlD
Dinoprost Tromethamine—Bimatoprost—AKR1C3—uterine cancer	0.00927	0.657	CrCbGaD
Dinoprost Tromethamine—TBXA2R—epithelium—uterine cancer	0.00744	0.0214	CbGeAlD
Dinoprost Tromethamine—PTGER3—myometrium—uterine cancer	0.0073	0.021	CbGeAlD
Dinoprost Tromethamine—TBXA2R—decidua—uterine cancer	0.00703	0.0202	CbGeAlD
Dinoprost Tromethamine—HPGDS—myometrium—uterine cancer	0.00631	0.0182	CbGeAlD
Dinoprost Tromethamine—PTGER1—renal system—uterine cancer	0.00606	0.0174	CbGeAlD
Dinoprost Tromethamine—PTGFR—myometrium—uterine cancer	0.00584	0.0168	CbGeAlD
Dinoprost Tromethamine—TBXA2R—female reproductive system—uterine cancer	0.00553	0.0159	CbGeAlD
Dinoprost Tromethamine—PTGER3—smooth muscle tissue—uterine cancer	0.00552	0.0159	CbGeAlD
Dinoprost Tromethamine—PTGER3—renal system—uterine cancer	0.00531	0.0153	CbGeAlD
Dinoprost Tromethamine—TBXA2R—vagina—uterine cancer	0.005	0.0144	CbGeAlD
Dinoprost Tromethamine—HPGDS—epithelium—uterine cancer	0.00495	0.0142	CbGeAlD
Dinoprost Tromethamine—HPGDS—uterine cervix—uterine cancer	0.00491	0.0141	CbGeAlD
Dinoprost Tromethamine—PTGER1—female reproductive system—uterine cancer	0.00485	0.014	CbGeAlD
Dinoprost Tromethamine—PTGER3—uterus—uterine cancer	0.00473	0.0136	CbGeAlD
Dinoprost Tromethamine—HPGDS—decidua—uterine cancer	0.00468	0.0135	CbGeAlD
Dinoprost Tromethamine—HPGDS—renal system—uterine cancer	0.00459	0.0132	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—myometrium—uterine cancer	0.00454	0.0131	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—myometrium—uterine cancer	0.0045	0.0129	CbGeAlD
Dinoprost Tromethamine—HPGDS—endometrium—uterine cancer	0.00444	0.0128	CbGeAlD
Dinoprost Tromethamine—PTGER1—female gonad—uterine cancer	0.00442	0.0127	CbGeAlD
Dinoprost Tromethamine—PTGFR—smooth muscle tissue—uterine cancer	0.00441	0.0127	CbGeAlD
Dinoprost Tromethamine—HPGDS—mammalian vulva—uterine cancer	0.0043	0.0124	CbGeAlD
Dinoprost Tromethamine—PTGER3—female reproductive system—uterine cancer	0.00426	0.0122	CbGeAlD
Dinoprost Tromethamine—HPGDS—uterus—uterine cancer	0.00409	0.0118	CbGeAlD
Dinoprost Tromethamine—PTGIR—epithelium—uterine cancer	0.00404	0.0116	CbGeAlD
Dinoprost Tromethamine—PTGIR—smooth muscle tissue—uterine cancer	0.00389	0.0112	CbGeAlD
Dinoprost Tromethamine—PTGER3—female gonad—uterine cancer	0.00387	0.0111	CbGeAlD
Dinoprost Tromethamine—PTGFR—uterus—uterine cancer	0.00378	0.0109	CbGeAlD
Dinoprost Tromethamine—PTGIR—renal system—uterine cancer	0.00374	0.0108	CbGeAlD
Dinoprost Tromethamine—HPGDS—female reproductive system—uterine cancer	0.00368	0.0106	CbGeAlD
Dinoprost Tromethamine—SLC22A11—renal system—uterine cancer	0.00365	0.0105	CbGeAlD
Dinoprost Tromethamine—SLC22A7—renal system—uterine cancer	0.00356	0.0102	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—uterine cervix—uterine cancer	0.00353	0.0102	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—epithelium—uterine cancer	0.00353	0.0102	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—uterine cervix—uterine cancer	0.0035	0.0101	CbGeAlD
Dinoprost Tromethamine—PTGFR—female reproductive system—uterine cancer	0.0034	0.00979	CbGeAlD
Dinoprost Tromethamine—HPGDS—female gonad—uterine cancer	0.00335	0.00963	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—decidua—uterine cancer	0.00333	0.00959	CbGeAlD
Dinoprost Tromethamine—HPGDS—vagina—uterine cancer	0.00333	0.00957	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—renal system—uterine cancer	0.0033	0.00951	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—renal system—uterine cancer	0.00327	0.00942	CbGeAlD
Dinoprost Tromethamine—TBXA2R—lymph node—uterine cancer	0.00323	0.00931	CbGeAlD
Dinoprost Tromethamine—Dinoprostone—CYP11A1—uterine cancer	0.00318	0.226	CrCbGaD
Dinoprost Tromethamine—SLC22A2—renal system—uterine cancer	0.00317	0.00912	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—endometrium—uterine cancer	0.00316	0.0091	CbGeAlD
Dinoprost Tromethamine—PTGFR—female gonad—uterine cancer	0.0031	0.00891	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—mammalian vulva—uterine cancer	0.00309	0.00889	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—mammalian vulva—uterine cancer	0.00306	0.00881	CbGeAlD
Dinoprost Tromethamine—PTGIR—female reproductive system—uterine cancer	0.003	0.00863	CbGeAlD
Dinoprost Tromethamine—SLC22A11—female reproductive system—uterine cancer	0.00292	0.00841	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—uterus—uterine cancer	0.00292	0.00839	CbGeAlD
Dinoprost Tromethamine—PTGIR—female gonad—uterine cancer	0.00273	0.00785	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—female reproductive system—uterine cancer	0.00265	0.00761	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—female reproductive system—uterine cancer	0.00262	0.00754	CbGeAlD
Dinoprost Tromethamine—PTGER3—lymph node—uterine cancer	0.00249	0.00716	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—female gonad—uterine cancer	0.00241	0.00693	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—vagina—uterine cancer	0.00239	0.00689	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—female gonad—uterine cancer	0.00238	0.00686	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—vagina—uterine cancer	0.00237	0.00682	CbGeAlD
Dinoprost Tromethamine—HPGDS—lymph node—uterine cancer	0.00215	0.00619	CbGeAlD
Dinoprost Tromethamine—SLC22A8—renal system—uterine cancer	0.00206	0.00592	CbGeAlD
Dinoprost Tromethamine—PTGFR—lymph node—uterine cancer	0.00199	0.00573	CbGeAlD
Dinoprost Tromethamine—PTGIR—lymph node—uterine cancer	0.00175	0.00505	CbGeAlD
Dinoprost Tromethamine—Immune system disorder—Progesterone—uterine cancer	0.00173	0.00508	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Etoposide—uterine cancer	0.00169	0.00497	CcSEcCtD
Dinoprost Tromethamine—Dinoprostone—CYP19A1—uterine cancer	0.00165	0.117	CrCbGaD
Dinoprost Tromethamine—Phlebitis—Etoposide—uterine cancer	0.00165	0.00482	CcSEcCtD
Dinoprost Tromethamine—Back pain—Progesterone—uterine cancer	0.00161	0.00473	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Progesterone—uterine cancer	0.0016	0.0047	CcSEcCtD
Dinoprost Tromethamine—Hyperventilation—Epirubicin—uterine cancer	0.00159	0.00466	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.00462	CcSEcCtD
Dinoprost Tromethamine—Burning sensation—Epirubicin—uterine cancer	0.00158	0.00462	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.0046	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Etoposide—uterine cancer	0.00156	0.00458	CcSEcCtD
Dinoprost Tromethamine—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00457	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Progesterone—uterine cancer	0.00155	0.00454	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—lymph node—uterine cancer	0.00155	0.00445	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—lymph node—uterine cancer	0.00153	0.00441	CbGeAlD
Dinoprost Tromethamine—Malaise—Progesterone—uterine cancer	0.00151	0.00441	CcSEcCtD
Dinoprost Tromethamine—Syncope—Progesterone—uterine cancer	0.0015	0.00439	CcSEcCtD
Dinoprost Tromethamine—Ventricular arrhythmia—Epirubicin—uterine cancer	0.00148	0.00434	CcSEcCtD
Dinoprost Tromethamine—Hyperventilation—Doxorubicin—uterine cancer	0.00147	0.00431	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Progesterone—uterine cancer	0.00147	0.0043	CcSEcCtD
Dinoprost Tromethamine—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00429	CcSEcCtD
Dinoprost Tromethamine—Burning sensation—Doxorubicin—uterine cancer	0.00146	0.00427	CcSEcCtD
Dinoprost Tromethamine—Cough—Progesterone—uterine cancer	0.00146	0.00427	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00426	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Progesterone—uterine cancer	0.00145	0.00424	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Progesterone—uterine cancer	0.00144	0.00422	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Progesterone—uterine cancer	0.00142	0.00416	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Progesterone—uterine cancer	0.0014	0.00411	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00411	CcSEcCtD
Dinoprost Tromethamine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00407	CcSEcCtD
Dinoprost Tromethamine—Ventricular arrhythmia—Doxorubicin—uterine cancer	0.00137	0.00401	CcSEcCtD
Dinoprost Tromethamine—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.004	CcSEcCtD
Dinoprost Tromethamine—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00398	CcSEcCtD
Dinoprost Tromethamine—Infection—Progesterone—uterine cancer	0.00135	0.00397	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Etoposide—uterine cancer	0.00135	0.00395	CcSEcCtD
Dinoprost Tromethamine—Shock—Progesterone—uterine cancer	0.00134	0.00393	CcSEcCtD
Dinoprost Tromethamine—Petechiae—Epirubicin—uterine cancer	0.00133	0.0039	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Progesterone—uterine cancer	0.00133	0.0039	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.0039	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Progesterone—uterine cancer	0.00132	0.00386	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00384	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00377	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Progesterone—uterine cancer	0.00127	0.00373	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00373	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Epirubicin—uterine cancer	0.00125	0.00368	CcSEcCtD
Dinoprost Tromethamine—Petechiae—Doxorubicin—uterine cancer	0.00123	0.00361	CcSEcCtD
Dinoprost Tromethamine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00359	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Progesterone—uterine cancer	0.00122	0.00358	CcSEcCtD
Dinoprost Tromethamine—Chills—Dactinomycin—uterine cancer	0.00122	0.00356	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Progesterone—uterine cancer	0.00121	0.00356	CcSEcCtD
Dinoprost Tromethamine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00356	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Progesterone—uterine cancer	0.00121	0.00355	CcSEcCtD
Dinoprost Tromethamine—Bronchospasm—Etoposide—uterine cancer	0.00121	0.00353	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00353	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.0035	CcSEcCtD
Dinoprost Tromethamine—Pain—Progesterone—uterine cancer	0.00116	0.00341	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Doxorubicin—uterine cancer	0.00116	0.0034	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00338	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Progesterone—uterine cancer	0.00112	0.00329	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Progesterone—uterine cancer	0.00111	0.00326	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00325	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00323	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00322	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Epirubicin—uterine cancer	0.00109	0.00321	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Epirubicin—uterine cancer	0.00109	0.00321	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Dactinomycin—uterine cancer	0.00109	0.00321	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Progesterone—uterine cancer	0.00108	0.00316	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Progesterone—uterine cancer	0.00108	0.00316	CcSEcCtD
Dinoprost Tromethamine—Malaise—Dactinomycin—uterine cancer	0.00106	0.00312	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00298	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Doxorubicin—uterine cancer	0.00101	0.00297	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Doxorubicin—uterine cancer	0.00101	0.00297	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00296	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Progesterone—uterine cancer	0.001	0.00294	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Dactinomycin—uterine cancer	0.000992	0.00291	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Progesterone—uterine cancer	0.000977	0.00286	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000976	0.00286	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000976	0.00286	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Progesterone—uterine cancer	0.000964	0.00282	CcSEcCtD
Dinoprost Tromethamine—Hypertonia—Epirubicin—uterine cancer	0.00096	0.00281	CcSEcCtD
Dinoprost Tromethamine—Infection—Dactinomycin—uterine cancer	0.000957	0.0028	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Epirubicin—uterine cancer	0.00095	0.00278	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Progesterone—uterine cancer	0.000932	0.00273	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Epirubicin—uterine cancer	0.000922	0.0027	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Epirubicin—uterine cancer	0.000918	0.00269	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Epirubicin—uterine cancer	0.000914	0.00268	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000909	0.00267	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Progesterone—uterine cancer	0.000901	0.00264	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Etoposide—uterine cancer	0.00089	0.00261	CcSEcCtD
Dinoprost Tromethamine—Hypertonia—Doxorubicin—uterine cancer	0.000888	0.0026	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Etoposide—uterine cancer	0.000886	0.0026	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000886	0.0026	CcSEcCtD
Dinoprost Tromethamine—Chills—Etoposide—uterine cancer	0.00088	0.00258	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Doxorubicin—uterine cancer	0.000879	0.00258	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Epirubicin—uterine cancer	0.000876	0.00257	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000873	0.00256	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Progesterone—uterine cancer	0.000866	0.00254	CcSEcCtD
Dinoprost Tromethamine—Rash—Progesterone—uterine cancer	0.000859	0.00252	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Progesterone—uterine cancer	0.000858	0.00251	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Doxorubicin—uterine cancer	0.000854	0.0025	CcSEcCtD
Dinoprost Tromethamine—Headache—Progesterone—uterine cancer	0.000853	0.0025	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Doxorubicin—uterine cancer	0.000849	0.00249	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Doxorubicin—uterine cancer	0.000845	0.00248	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000845	0.00248	CcSEcCtD
Dinoprost Tromethamine—Back pain—Etoposide—uterine cancer	0.000826	0.00242	CcSEcCtD
Dinoprost Tromethamine—Pain—Dactinomycin—uterine cancer	0.000823	0.00241	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Etoposide—uterine cancer	0.000821	0.00241	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000816	0.00239	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000811	0.00238	CcSEcCtD
Dinoprost Tromethamine—Nausea—Progesterone—uterine cancer	0.000809	0.00237	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Epirubicin—uterine cancer	0.000795	0.00233	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Dactinomycin—uterine cancer	0.000793	0.00233	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Etoposide—uterine cancer	0.000792	0.00232	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000787	0.00231	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000785	0.0023	CcSEcCtD
Dinoprost Tromethamine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000778	0.00228	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000778	0.00228	CcSEcCtD
Dinoprost Tromethamine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000773	0.00227	CcSEcCtD
Dinoprost Tromethamine—Malaise—Etoposide—uterine cancer	0.00077	0.00226	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Dactinomycin—uterine cancer	0.000761	0.00223	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Dactinomycin—uterine cancer	0.000761	0.00223	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Epirubicin—uterine cancer	0.000756	0.00221	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Etoposide—uterine cancer	0.00075	0.0022	CcSEcCtD
Dinoprost Tromethamine—Cough—Etoposide—uterine cancer	0.000745	0.00218	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Etoposide—uterine cancer	0.00074	0.00217	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Epirubicin—uterine cancer	0.000739	0.00217	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Etoposide—uterine cancer	0.000737	0.00216	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Doxorubicin—uterine cancer	0.000735	0.00216	CcSEcCtD
Dinoprost Tromethamine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000733	0.00215	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Etoposide—uterine cancer	0.000727	0.00213	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Epirubicin—uterine cancer	0.000723	0.00212	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Etoposide—uterine cancer	0.000718	0.0021	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Dactinomycin—uterine cancer	0.000709	0.00208	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Doxorubicin—uterine cancer	0.000699	0.00205	CcSEcCtD
Dinoprost Tromethamine—Infection—Etoposide—uterine cancer	0.000692	0.00203	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Dactinomycin—uterine cancer	0.000691	0.00202	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Doxorubicin—uterine cancer	0.000684	0.002	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Etoposide—uterine cancer	0.00068	0.00199	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Etoposide—uterine cancer	0.000674	0.00197	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Doxorubicin—uterine cancer	0.000669	0.00196	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Dactinomycin—uterine cancer	0.000659	0.00193	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Etoposide—uterine cancer	0.000651	0.00191	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Epirubicin—uterine cancer	0.000642	0.00188	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Etoposide—uterine cancer	0.000626	0.00183	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Etoposide—uterine cancer	0.000621	0.00182	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Etoposide—uterine cancer	0.000619	0.00182	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Epirubicin—uterine cancer	0.000612	0.00179	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Dactinomycin—uterine cancer	0.000612	0.00179	CcSEcCtD
Dinoprost Tromethamine—Rash—Dactinomycin—uterine cancer	0.000607	0.00178	CcSEcCtD
Dinoprost Tromethamine—Pain—Etoposide—uterine cancer	0.000596	0.00175	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Epirubicin—uterine cancer	0.000595	0.00174	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Doxorubicin—uterine cancer	0.000594	0.00174	CcSEcCtD
Dinoprost Tromethamine—Sweating—Epirubicin—uterine cancer	0.000587	0.00172	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Epirubicin—uterine cancer	0.000584	0.00171	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Epirubicin—uterine cancer	0.000578	0.00169	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Etoposide—uterine cancer	0.000574	0.00168	CcSEcCtD
Dinoprost Tromethamine—Nausea—Dactinomycin—uterine cancer	0.000572	0.00168	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Etoposide—uterine cancer	0.00057	0.00167	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Doxorubicin—uterine cancer	0.000567	0.00166	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Epirubicin—uterine cancer	0.00056	0.00164	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Etoposide—uterine cancer	0.000551	0.00161	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Etoposide—uterine cancer	0.000551	0.00161	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Doxorubicin—uterine cancer	0.000551	0.00161	CcSEcCtD
Dinoprost Tromethamine—Sweating—Doxorubicin—uterine cancer	0.000543	0.00159	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Doxorubicin—uterine cancer	0.00054	0.00158	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Doxorubicin—uterine cancer	0.000535	0.00157	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Doxorubicin—uterine cancer	0.000518	0.00152	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Etoposide—uterine cancer	0.000513	0.0015	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Etoposide—uterine cancer	0.0005	0.00147	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Epirubicin—uterine cancer	0.000499	0.00146	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Epirubicin—uterine cancer	0.000497	0.00146	CcSEcCtD
Dinoprost Tromethamine—Chills—Epirubicin—uterine cancer	0.000493	0.00145	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Etoposide—uterine cancer	0.000493	0.00144	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Etoposide—uterine cancer	0.000477	0.0014	CcSEcCtD
Dinoprost Tromethamine—Back pain—Epirubicin—uterine cancer	0.000463	0.00136	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Doxorubicin—uterine cancer	0.000462	0.00135	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Etoposide—uterine cancer	0.000461	0.00135	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Epirubicin—uterine cancer	0.00046	0.00135	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Doxorubicin—uterine cancer	0.000459	0.00135	CcSEcCtD
Dinoprost Tromethamine—Chills—Doxorubicin—uterine cancer	0.000456	0.00134	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Epirubicin—uterine cancer	0.000444	0.0013	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Etoposide—uterine cancer	0.000443	0.0013	CcSEcCtD
Dinoprost Tromethamine—Agitation—Epirubicin—uterine cancer	0.00044	0.00129	CcSEcCtD
Dinoprost Tromethamine—Rash—Etoposide—uterine cancer	0.000439	0.00129	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Etoposide—uterine cancer	0.000439	0.00129	CcSEcCtD
Dinoprost Tromethamine—Headache—Etoposide—uterine cancer	0.000437	0.00128	CcSEcCtD
Dinoprost Tromethamine—Malaise—Epirubicin—uterine cancer	0.000432	0.00126	CcSEcCtD
Dinoprost Tromethamine—Syncope—Epirubicin—uterine cancer	0.000429	0.00126	CcSEcCtD
Dinoprost Tromethamine—Back pain—Doxorubicin—uterine cancer	0.000428	0.00126	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Doxorubicin—uterine cancer	0.000426	0.00125	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Epirubicin—uterine cancer	0.000421	0.00123	CcSEcCtD
Dinoprost Tromethamine—Cough—Epirubicin—uterine cancer	0.000418	0.00122	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Epirubicin—uterine cancer	0.000415	0.00122	CcSEcCtD
Dinoprost Tromethamine—Nausea—Etoposide—uterine cancer	0.000414	0.00121	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Epirubicin—uterine cancer	0.000413	0.00121	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000411	0.0012	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Epirubicin—uterine cancer	0.000407	0.00119	CcSEcCtD
Dinoprost Tromethamine—Agitation—Doxorubicin—uterine cancer	0.000407	0.00119	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Epirubicin—uterine cancer	0.000403	0.00118	CcSEcCtD
Dinoprost Tromethamine—Malaise—Doxorubicin—uterine cancer	0.000399	0.00117	CcSEcCtD
Dinoprost Tromethamine—Syncope—Doxorubicin—uterine cancer	0.000397	0.00116	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Doxorubicin—uterine cancer	0.000389	0.00114	CcSEcCtD
Dinoprost Tromethamine—Infection—Epirubicin—uterine cancer	0.000388	0.00114	CcSEcCtD
Dinoprost Tromethamine—Cough—Doxorubicin—uterine cancer	0.000386	0.00113	CcSEcCtD
Dinoprost Tromethamine—Shock—Epirubicin—uterine cancer	0.000384	0.00113	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Doxorubicin—uterine cancer	0.000384	0.00112	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Doxorubicin—uterine cancer	0.000382	0.00112	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Epirubicin—uterine cancer	0.000381	0.00112	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Epirubicin—uterine cancer	0.000378	0.00111	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Doxorubicin—uterine cancer	0.000377	0.0011	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Doxorubicin—uterine cancer	0.000372	0.00109	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Epirubicin—uterine cancer	0.000365	0.00107	CcSEcCtD
Dinoprost Tromethamine—Infection—Doxorubicin—uterine cancer	0.000359	0.00105	CcSEcCtD
Dinoprost Tromethamine—Shock—Doxorubicin—uterine cancer	0.000356	0.00104	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Doxorubicin—uterine cancer	0.000353	0.00103	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Epirubicin—uterine cancer	0.000351	0.00103	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000349	0.00102	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Epirubicin—uterine cancer	0.000348	0.00102	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Epirubicin—uterine cancer	0.000347	0.00102	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Doxorubicin—uterine cancer	0.000338	0.00099	CcSEcCtD
Dinoprost Tromethamine—Pain—Epirubicin—uterine cancer	0.000334	0.000979	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Doxorubicin—uterine cancer	0.000325	0.000951	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Doxorubicin—uterine cancer	0.000322	0.000944	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Epirubicin—uterine cancer	0.000322	0.000943	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Doxorubicin—uterine cancer	0.000321	0.000942	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000319	0.000936	CcSEcCtD
Dinoprost Tromethamine—Pain—Doxorubicin—uterine cancer	0.000309	0.000906	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Epirubicin—uterine cancer	0.000309	0.000905	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Epirubicin—uterine cancer	0.000309	0.000905	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Doxorubicin—uterine cancer	0.000298	0.000873	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000296	0.000866	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Epirubicin—uterine cancer	0.000288	0.000843	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Doxorubicin—uterine cancer	0.000286	0.000837	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Doxorubicin—uterine cancer	0.000286	0.000837	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Epirubicin—uterine cancer	0.00028	0.000821	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Epirubicin—uterine cancer	0.000276	0.00081	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Epirubicin—uterine cancer	0.000267	0.000783	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Doxorubicin—uterine cancer	0.000266	0.00078	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Doxorubicin—uterine cancer	0.000259	0.00076	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Epirubicin—uterine cancer	0.000258	0.000757	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Doxorubicin—uterine cancer	0.000256	0.000749	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Epirubicin—uterine cancer	0.000248	0.000728	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Doxorubicin—uterine cancer	0.000247	0.000725	CcSEcCtD
Dinoprost Tromethamine—Rash—Epirubicin—uterine cancer	0.000246	0.000722	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Epirubicin—uterine cancer	0.000246	0.000721	CcSEcCtD
Dinoprost Tromethamine—Headache—Epirubicin—uterine cancer	0.000245	0.000717	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Doxorubicin—uterine cancer	0.000239	0.0007	CcSEcCtD
Dinoprost Tromethamine—Nausea—Epirubicin—uterine cancer	0.000232	0.00068	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Doxorubicin—uterine cancer	0.00023	0.000673	CcSEcCtD
Dinoprost Tromethamine—Rash—Doxorubicin—uterine cancer	0.000228	0.000668	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Doxorubicin—uterine cancer	0.000228	0.000667	CcSEcCtD
Dinoprost Tromethamine—Headache—Doxorubicin—uterine cancer	0.000226	0.000664	CcSEcCtD
Dinoprost Tromethamine—Nausea—Doxorubicin—uterine cancer	0.000215	0.000629	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	0.000124	0.00139	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—AKR1C3—uterine cancer	0.000124	0.00139	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CDKN2B—uterine cancer	0.000123	0.00139	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—FBXW7—uterine cancer	0.000122	0.00137	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	0.000122	0.00136	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PGR—uterine cancer	0.00012	0.00135	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AKR1C1—uterine cancer	0.00012	0.00135	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IGF1R—uterine cancer	0.00012	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—CXCL8—uterine cancer	0.000119	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—VEGFA—uterine cancer	0.000119	0.00133	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AKR1C1—uterine cancer	0.000117	0.00132	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AKR1C1—uterine cancer	0.000117	0.00132	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—NRAS—uterine cancer	0.000117	0.00132	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	0.000115	0.00129	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—YWHAE—uterine cancer	0.000115	0.00129	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SRD5A2—uterine cancer	0.000115	0.00129	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NDUFB11—uterine cancer	0.000115	0.00129	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—SMAD3—uterine cancer	0.000113	0.00126	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	0.000112	0.00126	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—CXCL8—uterine cancer	0.00011	0.00124	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—FBXW7—uterine cancer	0.00011	0.00124	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—CXCL8—uterine cancer	0.000108	0.00122	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—CXCL8—uterine cancer	0.000108	0.00121	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—CXCL8—uterine cancer	0.000108	0.00121	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—FGFR2—uterine cancer	0.000107	0.00121	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—STK11—uterine cancer	0.000107	0.0012	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CCL2—uterine cancer	0.000106	0.00119	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—MTHFR—uterine cancer	0.000105	0.00118	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—KRAS—uterine cancer	0.000101	0.00113	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SOCS3—uterine cancer	9.99e-05	0.00112	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—STK11—uterine cancer	9.63e-05	0.00108	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CCL2—uterine cancer	9.58e-05	0.00108	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CDKN2B—uterine cancer	9.57e-05	0.00107	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IGF1R—uterine cancer	9.29e-05	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—PIK3CA—uterine cancer	9.28e-05	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.27e-05	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—CXCL8—uterine cancer	9.25e-05	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AKR1C3—uterine cancer	9.24e-05	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—ESR1—uterine cancer	9.19e-05	0.00103	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AKR1C3—uterine cancer	9.04e-05	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AKR1C3—uterine cancer	9.04e-05	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SOCS3—uterine cancer	9.01e-05	0.00101	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PGR—uterine cancer	9e-05	0.00101	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—TP53—uterine cancer	8.98e-05	0.00101	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PGR—uterine cancer	8.81e-05	0.000989	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PGR—uterine cancer	8.81e-05	0.000989	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SMAD3—uterine cancer	8.73e-05	0.000981	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—NRAS—uterine cancer	8.69e-05	0.000975	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CDKN2B—uterine cancer	8.63e-05	0.000969	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—YWHAE—uterine cancer	8.59e-05	0.000964	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—HRAS—uterine cancer	8.59e-05	0.000964	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—YWHAE—uterine cancer	8.41e-05	0.000944	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—YWHAE—uterine cancer	8.41e-05	0.000944	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CXCL8—uterine cancer	8.4e-05	0.000943	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IGF1R—uterine cancer	8.38e-05	0.000941	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—CXCL8—uterine cancer	8.34e-05	0.000936	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—FGFR2—uterine cancer	8.33e-05	0.000935	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—EP300—uterine cancer	8.28e-05	0.00093	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—STAR—uterine cancer	8.28e-05	0.000929	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—AKR1B1—uterine cancer	8.28e-05	0.000929	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—FBXW7—uterine cancer	8.23e-05	0.000924	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCL2—uterine cancer	8.09e-05	0.000908	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—FBXW7—uterine cancer	8.06e-05	0.000905	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—FBXW7—uterine cancer	8.06e-05	0.000905	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SMAD3—uterine cancer	7.88e-05	0.000884	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—VEGFA—uterine cancer	7.85e-05	0.000881	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—NRAS—uterine cancer	7.75e-05	0.00087	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—AKT1—uterine cancer	7.58e-05	0.000851	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CXCL8—uterine cancer	7.57e-05	0.00085	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—PIK3CA—uterine cancer	7.57e-05	0.000849	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—FGFR2—uterine cancer	7.51e-05	0.000844	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—KRAS—uterine cancer	7.48e-05	0.00084	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—STK11—uterine cancer	7.2e-05	0.000808	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CCL2—uterine cancer	7.16e-05	0.000804	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—ESR1—uterine cancer	7.13e-05	0.0008	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—STK11—uterine cancer	7.04e-05	0.000791	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—STK11—uterine cancer	7.04e-05	0.000791	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CCL2—uterine cancer	7.01e-05	0.000787	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CCL2—uterine cancer	7.01e-05	0.000787	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—PIK3CA—uterine cancer	6.87e-05	0.000771	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—ERBB2—uterine cancer	6.75e-05	0.000757	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SOCS3—uterine cancer	6.74e-05	0.000757	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—NRAS—uterine cancer	6.74e-05	0.000756	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—KRAS—uterine cancer	6.67e-05	0.000749	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SOCS3—uterine cancer	6.6e-05	0.000741	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SOCS3—uterine cancer	6.6e-05	0.000741	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—POLD1—uterine cancer	6.5e-05	0.000729	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CDKN2B—uterine cancer	6.45e-05	0.000724	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—ESR1—uterine cancer	6.43e-05	0.000722	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CXCL8—uterine cancer	6.4e-05	0.000718	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—HRAS—uterine cancer	6.36e-05	0.000714	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CDKN2B—uterine cancer	6.32e-05	0.000709	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CDKN2B—uterine cancer	6.32e-05	0.000709	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCL2—uterine cancer	6.27e-05	0.000704	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IGF1R—uterine cancer	6.27e-05	0.000703	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CDKN1B—uterine cancer	6.25e-05	0.000701	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL8—uterine cancer	6.24e-05	0.0007	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—AKT1—uterine cancer	6.18e-05	0.000694	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IGF1R—uterine cancer	6.13e-05	0.000689	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IGF1R—uterine cancer	6.13e-05	0.000689	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—PIK3CA—uterine cancer	6.13e-05	0.000688	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—CXCL8—uterine cancer	6.11e-05	0.000685	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL8—uterine cancer	6.11e-05	0.000685	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—NRAS—uterine cancer	6.08e-05	0.000682	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—AKR1C1—uterine cancer	6.08e-05	0.000682	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—TP53—uterine cancer	5.93e-05	0.000666	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CTNNB1—uterine cancer	5.9e-05	0.000663	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SMAD3—uterine cancer	5.89e-05	0.000661	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—PIK3CA—uterine cancer	5.87e-05	0.000659	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PTEN—uterine cancer	5.85e-05	0.000657	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—KRAS—uterine cancer	5.8e-05	0.000651	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SMAD3—uterine cancer	5.77e-05	0.000647	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SMAD3—uterine cancer	5.77e-05	0.000647	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PTEN—uterine cancer	5.75e-05	0.000646	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—HRAS—uterine cancer	5.67e-05	0.000637	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CXCL8—uterine cancer	5.66e-05	0.000636	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCL2—uterine cancer	5.66e-05	0.000635	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—FGFR2—uterine cancer	5.62e-05	0.000631	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—AKT1—uterine cancer	5.61e-05	0.00063	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—EP300—uterine cancer	5.58e-05	0.000626	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CXCL8—uterine cancer	5.54e-05	0.000622	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CXCL8—uterine cancer	5.54e-05	0.000622	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—FGFR2—uterine cancer	5.5e-05	0.000617	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—FGFR2—uterine cancer	5.5e-05	0.000617	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—EP300—uterine cancer	5.49e-05	0.000616	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—RRM2—uterine cancer	5.42e-05	0.000608	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—PIK3CA—uterine cancer	5.33e-05	0.000598	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—PIK3CA—uterine cancer	5.29e-05	0.000594	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—DCN—uterine cancer	5.26e-05	0.00059	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—ERBB2—uterine cancer	5.23e-05	0.000587	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—KRAS—uterine cancer	5.23e-05	0.000587	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—VEGFA—uterine cancer	5.2e-05	0.000583	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—HRAS—uterine cancer	5.15e-05	0.000579	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NRAS—uterine cancer	5.13e-05	0.000576	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—AKT1—uterine cancer	5.01e-05	0.000562	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CXCL8—uterine cancer	4.96e-05	0.000557	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP11A1—uterine cancer	4.95e-05	0.000556	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—HRAS—uterine cancer	4.93e-05	0.000553	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CDKN1B—uterine cancer	4.84e-05	0.000544	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ESR1—uterine cancer	4.81e-05	0.00054	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—PIK3CA—uterine cancer	4.81e-05	0.000539	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—AKT1—uterine cancer	4.79e-05	0.000538	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—ERBB2—uterine cancer	4.72e-05	0.00053	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ESR1—uterine cancer	4.71e-05	0.000528	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ESR1—uterine cancer	4.71e-05	0.000528	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—AKR1C3—uterine cancer	4.68e-05	0.000525	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CTNNB1—uterine cancer	4.58e-05	0.000514	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—NRAS—uterine cancer	4.54e-05	0.00051	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CXCL8—uterine cancer	4.47e-05	0.000502	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PTEN—uterine cancer	4.46e-05	0.000501	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—NRAS—uterine cancer	4.45e-05	0.000499	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—NRAS—uterine cancer	4.45e-05	0.000499	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—HRAS—uterine cancer	4.45e-05	0.000499	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KRAS—uterine cancer	4.42e-05	0.000496	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CDKN1B—uterine cancer	4.37e-05	0.000491	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—AKT1—uterine cancer	4.35e-05	0.000489	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—AKT1—uterine cancer	4.32e-05	0.000485	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—EP300—uterine cancer	4.25e-05	0.000478	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCL2—uterine cancer	4.23e-05	0.000475	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCL2—uterine cancer	4.14e-05	0.000465	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCL2—uterine cancer	4.14e-05	0.000465	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CTNNB1—uterine cancer	4.13e-05	0.000463	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PIK3CA—uterine cancer	4.13e-05	0.000463	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PIK3CA—uterine cancer	4.06e-05	0.000456	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—VEGFA—uterine cancer	4.03e-05	0.000452	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PTEN—uterine cancer	4.02e-05	0.000452	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NRAS—uterine cancer	3.98e-05	0.000447	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CA—uterine cancer	3.96e-05	0.000444	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—HRAS—uterine cancer	3.95e-05	0.000443	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TP53—uterine cancer	3.93e-05	0.000441	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—AKT1—uterine cancer	3.93e-05	0.000441	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—KRAS—uterine cancer	3.91e-05	0.000439	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—PIK3CA—uterine cancer	3.87e-05	0.000435	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CA—uterine cancer	3.87e-05	0.000435	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—EP300—uterine cancer	3.84e-05	0.000431	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—KRAS—uterine cancer	3.83e-05	0.00043	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—KRAS—uterine cancer	3.83e-05	0.00043	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—HRAS—uterine cancer	3.75e-05	0.000422	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—STK11—uterine cancer	3.64e-05	0.000409	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP19A1—uterine cancer	3.64e-05	0.000409	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—VEGFA—uterine cancer	3.63e-05	0.000408	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CA—uterine cancer	3.59e-05	0.000403	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NRAS—uterine cancer	3.59e-05	0.000403	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ERBB2—uterine cancer	3.53e-05	0.000396	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CA—uterine cancer	3.52e-05	0.000395	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—PIK3CA—uterine cancer	3.52e-05	0.000395	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ERBB2—uterine cancer	3.45e-05	0.000388	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ERBB2—uterine cancer	3.45e-05	0.000388	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KRAS—uterine cancer	3.43e-05	0.000385	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—AKT1—uterine cancer	3.37e-05	0.000379	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CXCL8—uterine cancer	3.35e-05	0.000376	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—HRAS—uterine cancer	3.32e-05	0.000373	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—AKT1—uterine cancer	3.32e-05	0.000372	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CXCL8—uterine cancer	3.28e-05	0.000368	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CXCL8—uterine cancer	3.28e-05	0.000368	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CDKN1B—uterine cancer	3.27e-05	0.000367	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—HRAS—uterine cancer	3.25e-05	0.000365	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—HRAS—uterine cancer	3.25e-05	0.000365	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—AKT1—uterine cancer	3.23e-05	0.000363	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CDKN1B—uterine cancer	3.2e-05	0.000359	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CDKN1B—uterine cancer	3.2e-05	0.000359	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—AKT1—uterine cancer	3.16e-05	0.000355	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—AKT1—uterine cancer	3.16e-05	0.000355	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PIK3CA—uterine cancer	3.15e-05	0.000353	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KRAS—uterine cancer	3.09e-05	0.000347	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CTNNB1—uterine cancer	3.09e-05	0.000347	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TP53—uterine cancer	3.04e-05	0.000342	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CTNNB1—uterine cancer	3.02e-05	0.000339	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CTNNB1—uterine cancer	3.02e-05	0.000339	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PTEN—uterine cancer	3.01e-05	0.000338	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PTEN—uterine cancer	2.95e-05	0.000331	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PTEN—uterine cancer	2.95e-05	0.000331	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—AKT1—uterine cancer	2.94e-05	0.00033	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—HRAS—uterine cancer	2.91e-05	0.000327	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—AKT1—uterine cancer	2.87e-05	0.000323	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—AKT1—uterine cancer	2.87e-05	0.000323	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—EP300—uterine cancer	2.87e-05	0.000322	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PIK3CA—uterine cancer	2.84e-05	0.000319	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—EP300—uterine cancer	2.81e-05	0.000315	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—EP300—uterine cancer	2.81e-05	0.000315	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TP53—uterine cancer	2.75e-05	0.000308	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—MTHFR—uterine cancer	2.74e-05	0.000307	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—uterine cancer	2.72e-05	0.000305	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NRAS—uterine cancer	2.68e-05	0.000301	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—VEGFA—uterine cancer	2.66e-05	0.000299	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—uterine cancer	2.66e-05	0.000299	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NRAS—uterine cancer	2.63e-05	0.000295	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NRAS—uterine cancer	2.63e-05	0.000295	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—HRAS—uterine cancer	2.63e-05	0.000295	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—AKT1—uterine cancer	2.57e-05	0.000289	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—AKT1—uterine cancer	2.32e-05	0.00026	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KRAS—uterine cancer	2.31e-05	0.000259	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KRAS—uterine cancer	2.26e-05	0.000254	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KRAS—uterine cancer	2.26e-05	0.000254	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PIK3CA—uterine cancer	2.12e-05	0.000238	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PIK3CA—uterine cancer	2.08e-05	0.000233	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PIK3CA—uterine cancer	2.08e-05	0.000233	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TP53—uterine cancer	2.05e-05	0.000231	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TP53—uterine cancer	2.01e-05	0.000226	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TP53—uterine cancer	2.01e-05	0.000226	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HRAS—uterine cancer	1.96e-05	0.00022	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HRAS—uterine cancer	1.92e-05	0.000216	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HRAS—uterine cancer	1.92e-05	0.000216	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AKT1—uterine cancer	1.73e-05	0.000195	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AKT1—uterine cancer	1.7e-05	0.000191	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AKT1—uterine cancer	1.7e-05	0.000191	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTEN—uterine cancer	1.52e-05	0.000171	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—EP300—uterine cancer	1.45e-05	0.000163	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PIK3CA—uterine cancer	1.07e-05	0.000121	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—AKT1—uterine cancer	8.78e-06	9.86e-05	CbGpPWpGaD
